Skip to content

Effect of different gait conditions on cognitive performance and cortical activity in healthy older adults

Effect of different gait conditions on cognitive performance and cortical activity in healthy older adults

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00033953
Enrollment
60
Registered
2024-04-24
Start date
2024-05-02
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of different gait conditions on cognitive performance and cortical activity in healthy older adults

Interventions

Group 1: Barefoot group The randomized, controlled intervention study has a total duration of 16 weeks and includes five measurement appointments, each at four-week intervals - initial examination, t
the test subjects choose their own walking speed and maintain a perceived exertion of RPE = 2 up to a maximum of RPE = 3
not strenuous to very little strenuous. At the same time as the cognitive tests, the blood flow situation in the prefrontal cortex is recorded using functional near-infrared spectroscopy. During the 1
minimum activity time in week 12 = 4 hours on 5 days per week). Any activity that is at least "standing" and is not a sporting activity is counted as activity time. Subjects can also choose to use a p

Sponsors

Institut für Sport- und Bewegungsmedizin, Universität Hamburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: • Age and Status: 60 + years and pension • if secondary and/ or voluntary employment, in total less than or 5 hours per week • Ability to walk and no walking aids • no to little experience in walking barefoot; walking on socks is also included, as very similar movement patterns between walking barefoot and walking on socks • already moving as much/stand as much on your feet as the minimum wearing time in week 12 (5 hours per day on 4 days per week) dictates; also moving as much in the apartment on cold day (assuming allocation 'barefoot‘) —> respondent should not move extra, but should interact in the existing daily routine to avoid effects by increasing activity levels • Shoe size less than or equal to 47 and greater than or equal to 36 or trying on shoes before issuing the documents to be filled out, as only shoe sizes 36 to 47 can be served by the manufacturer • Signal variance less than 7.5 % (NIRx Medical Technologies, 2017)

Exclusion criteria

Exclusion criteria: • untreated hearing loss (if hearing aid, one that can register all sounds) • cognitive impairment due to acute or long-term medical condition • relevant neurological diseases; "relevant" means that neither the measurements (e.g., unrestricted operation of all keys and pedals of the VTS) nor the intervention (e.g., wearing times) can be affected • relevant psychiatric diseases • (serious) relevant orthopedic diseases or corrections in the lower extremities and trunk, especially no artificial joints, prostheses (except dentures or mamma prostheses) and orthoses • relevant vestibular diseases (balance) • relevant shoe inserts or elevations • relevant support stockings • relevant compression stockings • relevant acute or not yet fully healed injury (e.g. inflamed ankle joint) • untreated arterial hypertension at rest (from a blood pressure of 140/100 mmHg)

Design outcomes

Primary

MeasureTime frame
general cognitive abilities prefrontal blood flow situation (functional near-infrared spectroscopy) A total of five measurements were taken: Initial measurement (t1), interim measurement after four weeks (t2), interim measurement after 8 weeks (t3), final measurement after 12 weeks (t4), follow-up after 16 weeks (t5).

Secondary

MeasureTime frame
blood flow

Countries

Germany

Contacts

Public ContactNils Schumacher

Institut für Bewegungswissenschaft, Fakultät für Psychologie und Bewegungswissenschaft, Universität Hamburg

nils.schumacher@uni-hamburg.de+49 40 42838-9146

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026